Boomerang Early Feasibility Study
Brief description of study
The purpose of this research study is to learn more about the safety and performance of Sacral Nerve Stimulation when used in patients who have Crohn’s disease or ulcerative colitis.
The InterStim™ Neurostimulator (InterStim) will be used in every participant who agrees to participate and meets all the eligibility criteria for the research study.
Approximately 5 people with Crohn’s disease and 5 people with ulcerative colitis in the United States will take part in this research study for a total of 10 people.
You may receive a stipend for completing a study required colonoscopy or sigmoidoscopy with biopsy that is not part of the standard of care treatment. You can expect to receive the following:
● Crohn’s disease participants
o $375 for a complete colonoscopy and biopsy
● Left-sided ulcerative colitis participants
o $150 for a complete flexible sigmoidoscopy and biopsy
You may receive reimbursement for your travel related costs for the procedure/office visits and a stipend for your time completing each telemedicine visit.
● Travel reimbursement up to $50
● $25 for each fully completed telemedicine visit
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Crohn’s disease,ulcerative colitis
-
Age: Between 18 Years - 75 Years
-
Gender: All
Updated on
09 Mar 2024.
Study ID: 852592
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
